Rees D C, Liu Y T, Cox M J, Elliott P, Wainscoat J S
MRC Molecular Haematology Unit, Institute of Molecular Medicine, The John Radcliffe, Oxford, UK.
Thromb Haemost. 1997 Nov;78(5):1357-9.
Both factor V Leiden and the C677T methylenetetrahydrofolate reductase (MTHFR) gene mutation are associated with premature vascular disease, and yet are found at surprisingly high allele frequencies in European populations, 2.7% and 35% respectively. We have investigated the prevalence of these mutations in 87 UK residents over the age of ninety, to look for any evidence of their association with premature death. Five factor V Leiden heterozygotes were found, giving an allele frequency of 2.9%, similar to that in the general UK population. The frequency of the thermolabile C677T MTHFR mutation was 36% with 11% homozygotes, again similar to that in the UK population; these genotypes are in Hardy-Weinberg equilibrium, suggesting that there is not strong selection against the homozygous state. One person was both heterozygous for factor V Leiden and homozygous for the C677T mutation. This study suggests that neither factor V Leiden nor thermolabile MTHFR are risk factors for premature death.
因子V莱顿突变和C677T亚甲基四氢叶酸还原酶(MTHFR)基因突变均与早发性血管疾病相关,但在欧洲人群中却有着出奇高的等位基因频率,分别为2.7%和35%。我们调查了87名90岁以上英国居民中这些突变的流行情况,以寻找它们与过早死亡相关的任何证据。发现了5名因子V莱顿杂合子,等位基因频率为2.9%,与英国普通人群相似。不耐热的C677T MTHFR突变频率为36%,其中纯合子为11%,同样与英国人群相似;这些基因型处于哈迪-温伯格平衡,表明对纯合状态没有强烈的选择作用。有一人既是因子V莱顿杂合子又是C677T突变纯合子。这项研究表明,因子V莱顿突变和不耐热的MTHFR均不是过早死亡的危险因素。